recent clinical data showed that moderate-severe hypertensives who were optimally controlled by atenolol-based treatment over a 10-year period were less likely to die from myocardial infarction than those suboptimally controlled , irrespective of a rise in serum triglyceride levels .
C0004147
atenolol
C0027051
myocardial infarction